electroCore, Inc. (ECOR)

[Fezziwig2008]

On ECOR -“A recent paper has proposed, based on two case studies, the use of nVNS to manage
respiratory symptoms in COVID-19 patients . They showed that nVNS decreased the use of
opioids and cough suppressant medication, and promoted relief from chest tightness and shortness of breath, improving lung clearance. As both taVNS and nVNS are very easy to administer and studies have shown they can increase vagus nerve activity, they both are suggested as potential techniques in the treatment of COVID-19 patients to control inflammation and decreased respiratory discomfort associated with respiratory symptoms”

In “Neuromodulation and Inflammatory Reflex: Perspectives on the Use of Non-Invasive Neuromodulation in the Management of Disorders Related to COVID-19”

https://poseidon01.ssrn.com/delivery.php?ID=798074116064001076064087078007120011061088038065086068107116100011029008100094113105106042008122106100015022110118004029125085007083095016044095023073007085001080006051093045127119029002106127030002065103065116095070088094003101090088082011097075119093&EXT=pdf